New Abilities of Administration of Tiotropium Bromide Using the Aerosol Delivery Device Respimat®

Pulmonologiya - Russian Federation
doi 10.18093/0869-0189-2013-0-5-70-80
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific and Practical Reviewed Journal Pulmonology

Related search

Tiotropium Bromide: An Update

Open Respiratory Medicine Journal
PulmonaryRespiratory Medicine
2009English

Once-Daily Tiotropium Respimat® Add-On Therapy Has a Safety Profile Comparable With Placebo in Children and Adolescents

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Tiotropium Respimat® Improves Physical Functioning in Chronic Obstructive Pulmonary Disease

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2010English

Cost-Effectiveness of Aclidinium Bromide Compared With Tiotropium Bromide From the Perspective of Copd Patient Populations

International Journal of Medicine and Pharmacy
2014English

In VitroEvaluation of a Device for Intra-Pulmonary Aerosol Generation and Delivery

Aerosol Science and Technology
Materials SciencePollutionEnvironmental Chemistry
2015English

ENHANZE® Drug Delivery Technology: A Novel Approach to Subcutaneous Administration Using Recombinant Human Hyaluronidase 20

Drug Delivery
MedicinePharmaceutical Science
2019English

Tiotropium Bromide in Therapy of Chronic Obstructive Pulmonary Disease: A Recipe for Success

Pulmonologiya
PulmonaryRespiratory Medicine
2011English

Tiotropium Bromide in the Routine Care of GOLD Stage II COPD Patients: A Pharmaeconomic Evaluation

Farmeconomia. Health economics and therapeutic pathways
2011English

Use of Tiotropium Bromide in an Adolescent With Adrenal Suppression Secondary to Inhaled Mometasone Furoate

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy